Tim Biggam

Tim Biggam

InvestorPlace Contributor

Delta Derivatives Tim Biggam is a veteran option strategy specialist and develops disciplined trading strategies for high- and low-volatility market environments.

He previously served as the Lead Option Strategist at Thinkorswim and the Chief Option Strategist at MF Global. Tim can be seen regularly on CBOE-TV, CNBC, Bloomberg TV, and BNN.

Recent Articles

Time for Freeport-McMoRan Inc (FCX) Stock to Take a Breather

By Tim Biggam, InvestorPlace Contributor

With FCX stock overbought and copper looking toppy, Freeport-McMoRan should consolidate, making this a smart play.

Hit the Bull’s-Eye in Target Corporation (TGT) Stock

By Tim Biggam, InvestorPlace Contributor

Shares of Target (TGT) are at multi-year lows in price and valuation and sporting a nearly 4% dividend. The time is now to target TGT stock.

Short Tesla Motors Inc (TSLA) Stock While It’s Overhyped

By Tim Biggam, InvestorPlace Contributor

Tesla Motors (TSLA) has rallied more than 30% since December and just got an upgrade. That's the perfect contrarian setup for TSLA stock.

ProShares Ultra VIX Short-Term Futures ETF (UVXY): Feed the Bear!

By Tim Biggam, InvestorPlace Contributor

The double-leveraged ProShares Ultra VIX Short-Term Futures ETF (UVXY) is the perfect way to play a potential market selloff.

SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!

By Tim Biggam, InvestorPlace Contributor

Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon.

Load More